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The respiratory syncytial (RS) virus attachment glycoprotein G is a type II transmembrane glycoprotein and an important
target of the host immune response. Antigenic variability of the G protein is postulated to contribute to the ability of the virus
to evade established immune responses. A glycoprotein G monospecific polyclonal antiserum from a nonhuman primate was
used to select for an antibody resistant RS virus. The mutant virus was resistant to neutralization by the selecting antiserum
and by the sera from three other G-protein immunized primates. G-protein amino acid changes were found at residues 61
(Phe to Leu), 174 (Ser to Cys), and 183 (Trp to Leu). Thus the mutant protein had amino acid changes in the transmembrane
domain (61) and the central ectodomain (174 and 183). The change at amino acid 174 resulted in five rather than the usual
four Cys found in the conserved central region of the ectodomain. These data demonstrate that an RS virus with resistance
to neutralization by polyclonal antibodies can be selected readily in cell culture. In addition, only a limited number of amino
acid changes is required to produce the resistant phenotype. © 1999 Academic Press
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Respiratory syncytial (RS) virus is the most commonly
dentified viral agent of lower-respiratory-tract infections
mong infants and young children. Infants may be in-
ected with RS virus in the presence of maternally de-
ived antibodies and reinfections occur throughout life.
hus RS virus is capable of establishing infections in the
resence of preexisting immunity (Collins et al., 1996).
ntigenic variability between the two major antigenic
roups may contribute to the capacity of these viruses to
vade the host immune response and establish reinfec-
ions (Mufson et al., 1987).
The RS virus attachment glycoprotein G is a type II
embrane protein that is modified by the addition of both
- and O-linked sugars. Immunization with the G protein
timulates protective immune responses in rodents, and
umans develop antibodies to the G protein after RS
irus infections (Collins et al., 1996). The G protein varies
etween the two antigenic groups of RS virus (Johnson et
l., 1987). There is additional G protein variability within
he antigenic groups with amino acid differences of as
reat as 20% in single epidemic period (Cane et al.,
991). This exceeds the 10% differences found among the
A proteins of drift strains of influenza A virus. Approx-
mately half of the nucleotide changes result in amino
cid coding changes among circulating RS virus G pro-
eins, suggesting that there may be a selective advan-
1 To whom reprint requests should be addressed. Fax: (205) 975-
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230age, such as immune escape, associated with these
hanges (Johnson and Collins, 1989; Cane et al., 1991;
ullender et al., 1991). Thus G-protein variability is pos-
ulated to contribute to the ability of RS virus to evade
mmune responses.
The antigenic structure of the G protein has been
xplored using murine monoclonal antibody (MAb) es-
ape mutants of the G protein. In vitro selection of variant
iruses has resulted in G-protein mutations due to frame
hifts, premature stop codons, substitutions, and hyper-
utations (Garcia-Barreno et al., 1990; Palomo et al.,
991; Rueda et al., 1991, 1994). Substitution mutations
ave resulted in G proteins with two or three instead of
he usual four cysteine residues in the ectodomain of the
rotein (Rueda et al., 1994; Martinez et al., 1997; Walsh et
l., 1998). One of the limitations of the selection of mu-
ants with murine MAbs is that to what extent primate
ntibodies might recognize the same or different anti-
enic sites is unknown (Palomo et al., 1991; Watkins et
l., 1996).
The selection of viral escape mutants with polyclonal
ntibodies has been reported, but not for RS virus (Faze-
as de St. Groth, 1969; Laver and Webster, 1968; Reitz et
l., 1988). The presence in serum of antibodies to multi-
le antigenic sites might make the selection of resistant
iruses more difficult (Laver and Webster, 1968; Yewdell
t al., 1979; Lambkin et al., 1994). In the work reported
ere, one goal was to determine whether an escape
utant of RS virus could be selected with a polyclonal
rimate antiserum. If such a mutant virus could be ob-
ained, then the G-protein residues that changed could
e determined. This would provide information as to the
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231RESPIRATORY SYNCYTIAL VIRUS RESISTANCE TO NEUTRALIZATION-protein residues that are involved in maintaining anti-
enic sites that participate in recognition by primate
olyclonal antibodies. These studies are particularly rel-
vant because polyclonal and monoclonal antibody
reparations are being used in children for passive im-
unoprophylaxis against RS virus (AAP, 1998).
RESULTS
election of an antibody resistant virus
RS virus was incubated with dilute serum from a mon-
ey (M590) that had been immunized with a vaccinia
irus recombinant that expresses the RS virus G protein.
nitial passages of virus in a 1% concentration of M590
erum revealed viral cytopathic effect (CPE), whereas
irus incubated in 5% serum did not produce CPE. The
erum concentration was gradually increased with pas-
ages in serum as follows: 7 in 1%, three in 2%, 2 in 3%,
in 4%, and finally 10 passages in 5% M590 serum
Vandepol et al., 1986). For passages seven to nine in 5%
erum, virus was diluted 103- or 104-fold before passage.
he final virus, M5p10, grew in the presence of 5% M590
erum, whereas the original A2 virus did not. As a control
or the multiple passages, the parent A2 RS virus also
as passaged with complement but without M590 se-
um. This virus was analyzed after 21 passages (A2p21).
ucleotide sequence determination of the M5p10
irus
The nucleotide sequence of the glycoprotein G gene
DNA was determined (Walsh et al., 1998). As compared
o the parent A2 virus G-protein mRNA nucleotide se-
uence three substitution mutations occurred in the
5p10 virus (nucleotides: 199 U to C, 535 A to U, and 563
to U). All three substitutions resulted in changes in the
educed amino acid sequences. One change (Phe61 to
eu) was in the transmembrane domain that spans
mino acids 38–66. Two changes were in the central
egion of the ectodomain. The change at residue 174
FIG. 1. Linear representation of the G protein. Amino acid numbers ar
ndicated. The open box (tm) is the transmembrane domain; cysteine res
he strictly conserved 13 amino acid central region. Selected amino ac
eginning and end), for the M5p10 virus only residues that differ from th
equences for the residues that changed.rom Ser to Cys was within the strictly conserved 13 rmino acid region of the protein. This resulted in five
entral Cys residues, something that has not been pre-
iously reported in escape mutants of RSV (Martinez et
l., 1997). The third change was Trp183 to Leu. Thus the
5p10 variant had changes in both the transmembrane
nd ectodomains (Fig, 1). The A2p21 virus G-protein
ene had no nucleotide sequence differences relative to
he parent A2 virus.
The M5p10 virus was plaque purified; three separate
laques from the first round of purification were taken
hrough two additional rounds of plaque purification. The
hree separate plaque-derived viruses were analyzed,
5p10.1, M5p10.2, and M5p10.3. Nucleotide sequence
etermination of the glycoprotein G gene of the three
laque purified viruses showed that all three viruses had
he three differences relative to the A2 G gene sequence
s described above for the M5p10 virus. The M5p10.1
lso had a substitution mutation at base 627 from A to T
n the midst of a run of 7 adenosines (Cane et al., 1993).
he substitution resulted in an amino acid change from
ys204 to Asn relative to the M5p10 and the A2 G-gene
rotein sequences.
esistance to neutralization
The M5p10.3 virus was tested for resistance to neu-
ralization by the selecting M590 serum and sera from
hree other G-protein immunized primates (Table 1). The
5p10.3 virus had a reduced susceptibility to neutraliza-
ion by all four sera, ranging from four- to onefold. Mean
eutralizing titers were reduced over fourfold, from a
ean titer (log2) of 5.3 for A2 to 2.8 for M5p10.3 (P 5
.04).
-protein expression
G-protein expression by the M5p10 mutant virus was
ssessed. The A2 and the M5p10 viruses produced G
roteins in the cell lysates and media of infected cells
hat were indistinguishable in mobility and immunoblot
n at the top. The protein is shown as the dark bar, with N and C termini
are marked (c). The shaded box and the underlined residues represent
dues from the A2 and M5p10 viruses are shown (numbered above at
irus are shown. The specific amino acid numbers are given below thee show
idues
id resi
e A2 veactivity (Fig. 2) (Walsh et al., 1998). Cell surface expres-
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232 SULLENDER AND EDWARDSion of the G protein in M5p10 virus infected cells was
emonstrated by cell surface immunofluorescence (not
hown). Thus neither the change in the transmembrane
omain nor the changes in the central region of the
ctodomain interfered with the ability of the G protein to
ndergo transport to the cell surface and presumably
ormal folding.
eactivity with MAbs
M5p10 virus G-protein reactivity with murine MAbs
as tested (Table 2). The MAbs used depend on the
resence of different regions of the G protein for reac-
ivity (Sullender, 1995). Four MAbs that are cross-reactive
mong both group A and B RS viruses maintained reac-
ivity and were reactive with the parent A2 and the M5p10
irus. Among the group-A-specific MAbs, some MAbs
aintained and others lost reactivity with the M5p10
irus G protein. Two of the MAbs that lost reactivity are
ependent on the presence of the central region (region
, amino acids 174–214) of the G protein for reactivity.
ther central region MAbs, and all of the regions 1 and
MAbs maintained reactivity.
DISCUSSION
An RS virus escape mutant was selected with a poly-
lonal primate antiserum. The selection of resistant vi-
uses with polyclonal antibodies has been considered
ore difficult, even given the quasispecies nature of
hese viruses (Laver and Webster, 1968; Yewdell et al.,
979; Domingo and Holland, 1994; Lambkin et al., 1994).
he M5p10 mutant virus was selected readily by pas-
age in the presence of gradually increasing concentra-
ions of antiserum. This is in agreement with the experi-
nce with other negative-stranded RNA viruses, such as
nfluenza virus and vesicular stomatitis virus, where mu-
ants have been similarly produced (Laver and Webster,
968; Vandepol et al., 1986).
TABLE 1
Neutralizing Activity of Primate Sera Against
Escape Mutant Virus M5p10.3
Animal Mean 6 SD
irus M590 M589 M592 M593
2 160 80 20 10 5.3 6 1.8
5p10 10 10 ,10 ,10 2.8 6 0.6
Note. Antibody titers determined by microneutralization assay with
wo fold dilutions beginning at 1:10 of sera from primates immunized
ith the G protein of RSV (Anderson et al., 1985; Falsey and Walsh,
998). Titers shown are the reciprocal of the highest dilution at which
50% reduction in viral replication was observed; for calculations a
alue of 1:5 was used if the titer was ,1:10. Geometric means are given
n log2, Student t test P 5 0.04.Changes in only three amino acids resulted in the sntibody-resistant phenotype. The escape virus M5p10
ad one amino acid change in the transmembrane do-
ain and two changes in the central region of the G-
rotein ectodomain as compared to the parent A2 virus.
ecause all three changes were present in the virus with
he resistant phenotype, any one or any combination of
he three changes might have resulted in the resistant
henotype. Changes in the central region are known to
nterfere with antibody reactivity; mutants selected by
eutralizing murine MAbs also have had changes in this
egion (Rueda et al., 1994; Walsh et al., 1998). The M5p10
irus lost immunofluorescence reactivity with MAb 021-
G. MAb 021-2G has neutralizing activity in cell culture
Martinez and Melero, 1998). Testing of mutants selected
ith other MAbs has shown that changes in the central
egion of the G protein can abrogate reactivity with MAb
21-2G (Martinez et al., 1997). Thus it seems likely that
oth primate and murine antibodies have reactivity with
n epitope or epitopes that depend on the presence of
pecific residues in the central region of the G protein to
aintain a reactive structure. However, the change in the
ransmembrane domain also may contribute to the loss
f antibody reactivity, particularly in regard to neutraliza-
ion (Reitz et al., 1988). The residues that have changed
ay be directly involved in contact with antibodies (Air et
l., 1990; Laver et al., 1990). More distant effects on
rotein conformation which interfere with antibody bind-
ng are also possible (Diamond et al., 1985; Yewdell et al.,
993).
Interestingly, the M5p10 virus had a reduced suscep-
ibility to neutralization not only by the selecting serum
ut also by sera from three other G-protein-immunized
rimates. Thus the limited changes in the M5p10 G
rotein were sufficient to interfere with recognition by
ore than just the selecting antiserum. Potential expla-
ations for this include that the repertoire of antigenic
ites recognized by neutralizing antibodies is restricted
n number, so that escape mutants that alter one or a few
pitopes become resistant to sera from multiple animals
hat also recognize only these few sites. Alternatively, the
FIG. 2. Immunoblot analysis of G-protein expression. Cell lysates
lanes 1–3) and media (lanes 4–6) from RS-virus (M5p10, lanes 1 and 4;
2, lanes 2 and 5)- or mock (lanes 3 and 6)-infected HEp-2 cells were
eparated by SDS–PAGE and transferred to PVDF membranes. Mem-
ranes were incubated with the G-protein-specific MAb L9, goat anti-
ouse horse radish peroxidase, a chemiluminescent substrate, and
xposed to radiographic film. The migration of prestained markers is
hown to the left of the figure in kDa. Mature G protein is indicated (-G).
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233RESPIRATORY SYNCYTIAL VIRUS RESISTANCE TO NEUTRALIZATION5p10 mutations may have resulted in changes in pro-
ein conformation that abrogate reactivity at multiple an-
igenic sites (Diamond et al., 1985; Reitz et al., 1988).
The G-protein changes of the M5p10 virus are of par-
icular interest because the central region of the G pro-
ein has been postulated to be critical for the structure
nd function of the protein (Johnson et al., 1987). Be-
ween the two antigenic groups of RS virus there are 13
mino acids (amino acids 163–176) that are strictly con-
erved among all the described naturally occurring RS
irus G proteins (Johnson et al., 1987; Cane et al., 1991;
ullender et al., 1991). A proposed three-dimensional
odel for the G protein suggests that the central hydro-
hobic region forms a cystine noose with two disulfide
onds among the four cysteine residues (Cys173-Cys186
nd Cys176-Cys182) (Langedijk et al., 1996). Synthetic
eptides derived from the central region of the G protein
nd expressed peptides including this region have been
sed as immunogens in animals and confer protection
gainst RS virus challenge (Trudel et al., 1991; Power et
l., 1997; Simard et al., 1995). The central region of the G
rotein appears to mediate the eosinophilic response
hat follows viral challenge after G-protein immunization
Openshaw et al., 1992; Sparer et al., 1998; Tebbey et al.,
998). Thus the central region of the G protein may play
role in both protective and immunopathogenic re-
ponses to RS virus infections.
As shown by the M5p10 and other RS virus escape
utants, RS virus is infectious even with G proteins that
ave changes in the central region and contain two,
hree, or five rather than the usual four Cys (Rueda et al.,
994; Martinez et al., 1997; Walsh et al., 1998). A mutant
S virus (cp52) that lacks the G and SH proteins grows
s well as its viral parent in cell culture but is restricted
or growth in animals (Karron et al., 1997). Thus replica-
ion in cell culture does not necessarily predict replica-
ion in animals. Growth curves of the M5p10 virus have
ot been determined, but as a preparation for testing by
eutralization, it grew readily to titers of ;106, within a
og10 dilution of the titer of the parent virus. Whether the
5p10 virus might, like the cp52 virus, be restricted for
rowth in animals remains to be determined.
A G-protein fragment (amino acids 130–230) that in-
ludes the central region of the G protein is being tested
s a candidate RS virus vaccine in phase I human trials
Siegrist et al., 1999). Functional constraints for replica-
ion in animals may restrict G-protein change in the
entral region (Johnson et al., 1987). If so, an immuniza-
ion approach that stimulates high titers of neutralizing
ntibodies that recognize this region might be success-
ul against a wide variety of RS virus isolates (Borrego et
l., 1993). However, should the circulating viruses be
ble to evade antibodies against this region as readily as
he mutant described here, the utility of such a vaccina-
ion approach may be more limited. For example, anti-
enic variants appeared rapidly in cattle immunized with mynthetic peptides as vaccines against foot-and-mouth
isease virus and then challenged with live virus
Taboga et al., 1997). Hepatitis B immune globulin is
iven to reduce reinfections among recipients of liver
ransplants for hepatitis-B-virus-related liver failure.
owever, reinfections still occur, and some of these
einfections appear to be caused by immune escape
utants (Ghany et al., 1998). The ability to select poly-
lonal antibody resistant RS viruses in cell culture sug-
ests the possibility that this also might occur among
umans should be considered as passive immunopro-
hylaxis approaches receive increasingly widespread
se among children (AAP, 1998).
METHODS
ells, viruses, sera, monoclonal antibodies
HEp-2 and Vero cells were grown as previously de-
cribed. HEp-2 cells were used for viral escape mutant
rowth and selection and viral stock preparation. Vero
ells were used for plaque purification and for plaque
ssays for viral titer determination (Sullender et al., 1990;
ullender and Britt, 1996). Viruses that had undergone
laque purification in Vero cells were subsequently
rown in HEp-2 cells to prepare viral stocks for analysis.
our African green monkeys were immunized with a
accinia virus recombinant (vAG301, 1 3 103 PFU intra-
ermally) that expressed the RS virus (A2) G protein
Stott et al., 1986). Sera obtained 21 days after the immu-
ization contained neutralizing antibodies to RS virus
see Table 1; unpublished data, G. Wertz (UAB), W. Sul-
ender, and K. Soike (Tulane Regional Primate Research
enter)]. Public Health Service and institutional guide-
ines were followed in animal experiments. Several in-
estigators (see Table 1 and acknowledgments) gener-
usly provided monoclonal antibodies.
election of escape mutants
Plaque-purified A2 strain RS virus was incubated with
ilute serum from monkey M590 and 5% guinea pig
omplement and adsorbed to HEp-2 cells. The inoculum
as removed, and fresh medium containing the same
oncentration of antiserum was added (Garcia-Barreno
t al., 1990; Walsh et al., 1998). When cytopathic effect
CPE) was evident, the infected cells were dislodged,
nd clarified medium was carried through the same
election process.
ucleotide sequence determination
Nucleotide sequence determinations of the G-protein
enes were performed from polymerase-chain-reaction-
mplified cDNAs by automated sequencing on an ABI
RISM 377 DNA Sequencer in the UAB core facility
Sullender et al., 1991, 1998; Walsh et al., 1998). Viral
RNA was used as a template for the synthesis of cDNA
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234 SULLENDER AND EDWARDSrom primer F164 (GTTATGACACTGGTATACCAACC, com-
lementary to nucleotides 164–186 in the CH18537 virus
-gene sequence). The synthetic oligonucleotides used
s amplification primers were G10 (GCAAACATGTC-
AAAAACAAG, nucleotide 10–30 in the A2 virus G gene
equence) and F164. The amplification and internal se-
uencing primers were designed based on published G
nd F nucleotide sequences (Wertz et al., 1985; Johnson
nd Collins, 1988). Nucleotide and deduced amino acid
equences were analyzed using the University of Wis-
onsin Genetics Computer Group programs (Genetics
omputer Group, 1991).
mmunoblotting, immunofluorescence, and
eutralization assays
Immunoblotting was performed as previously de-
cribed (Sullender, 1995). The proteins in cell lysates
ere separated by electrophoresis on SDS–polyacryl-
mide gels, transferred to polyvinylidene fluoride mem-
ranes, and detected with dilute primary antibody, per-
xidase-conjugated secondary antibody, and chemilumi-
escent reagent. Immunofluorescence was performed
n infected or uninfected HEp-2 cells fixed to multiwell
lass slides as previously described (Sullender, 1995).
ell surface immunofluorescence was performed in a
imilar manner except that cells were grown on cover-
TABLE 2
Immunofluorescence Reactivity of RS Virus G-Protein-Specific
Abs with Parent A2 Virus and Escape Mutant M5p0 Virus G Pro-
eins
Group reactivity A2 M5p10
and B Cross-Reactive
egion 1 (131-2g,a 021/1Gb) 1 1
egion 2 (central region) (L9,c 29d) 1 1
Specific
egion 2 (central region)
21/2G,b 130-6da 1 2
3Gb 1 1
egion 3 130-2g,a 78Gb 1 1
Note. Immunofluorescence reactivity of G-protein-specific MAbs was
ested against G proteins expressed in virus-infected HEp-2 cells. The
Abs are grouped under reactivity as to cross-reactivity with both A
nd B group G proteins or A group specificity. Reactivity is shown as
1) or (2). Previous work defined regions of the G protein whose
resence was required for reactivity with MAbs. Region 1 is G-protein
mino acids (aa) 1–173 and includes the cytoplasmic and transmem-
rane domains, and part of the ectodomain; region 2 is aa 174–214 and
ncludes the central portion of the ectodomain; and region 3 is aa
15–298 and includes the C-terminal region of the ectodomain (Sul-
ender, 1995).
a MAb from L. Anderson (Anderson, et al., 1988).
b MAb from J. Melero (Garcia-Barreno et al., 1989; Rueda, et al., 1994).
c MAb from E. Walsh (Walsh et al., 1989).
d MAb from G. Taylor.lips and fixed with paraformaldehyde. Antibody titersere determined by microneutralization assay as previ-
usly described (Anderson et al., 1985; Falsey and
alsh, 1998). Titers were calculated as the reciprocal of
he highest dilution at which a 50% reduction in viral
eplication was observed.
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